A study to compare the efficacy of Blinatumomab and Inotuzumab-ozogamicin as a first or second line novel agent therapy in patients with B-cell acute lymphocytic leukemia
Latest Information Update: 09 Dec 2020
At a glance
- Drugs Blinatumomab (Primary) ; Inotuzumab ozogamicin (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 01 Dec 2020 Results published in the Cancer.
- 17 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association